aod9604 australia Peptide — 2mg, 5mg, 10mg AOD9604

From what the study suggests, AOD 9604 may assist in the transition of these precursor cells into a more mature form

Koipeptides does not supply compounded preparations of any kind

News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004

(2001, Int J Obes) showed that chronic treatment with AOD-9604 restored repressed beta-3 AR mRNA levels in obese mice toward lean-mouse values, characterizing a chronic-treatment mechanism that complements the fragment's acute lipolytic action

AOD-9604 has been studied for its safety profile and is considered to have minimal side effects compared to many other treatments for weight management